Fernández-Pérez Juan, Pommepuy Isabelle, Michal Michael, Michal Michal, Cleven Arjen H G, Bouvier Corinne, Gomez-Brouchet Anne, Weingertner Noelle, Papke David J, Jo Vickie Y, Garcia Jeremy, Agaimy Abbas, Azmani Rihab, Bourdon Aurelien, Hostein Isabelle, Soubeyran Isabelle, Alame Melissa, Velasco Valérie, Coindre Jean-Michel, Le Loarer François, Perret Raul Ezequiel
Department of Pathology, Bordeaux University Hospital, Bordeaux, France.
Department of Pathology, Limoges University Hospital, Limoges, France.
Mod Pathol. 2025 Jun 11;38(10):100810. doi: 10.1016/j.modpat.2025.100810.
Pseudoendocrine sarcoma (PS) is a recently described neoplasm of uncertain differentiation, characterized by recurrent CTNNB1 mutations, frequent paravertebral location, and a neuroendocrine-like histomorphology. In this study, we report the clinicopathologic, immunohistochemical, transcriptomic, and epigenetic findings of 12 PS cases. The tumors affected 7 men and 5 women with a median age of 66 years and were located in the paraspinal/paravertebral region (n = 11) and the thigh (n = 1). Median tumor size was 82 mm (range, 32-170 mm). Histologically, the tumors comprised sheets and nests of epithelioid-to-ovoid cells with uniform nuclei and speckled chromatin, frequently associated with extracellular hyaline globules and fibrovascular cords/septa. Uncommon findings included microcalcifications, myxoid stroma, pseudopapillary, pseudoglandular, microcystic or corded architecture, and lumen and rosette-like structures. Necrosis was absent, and mitotic activity was low. On immunohistochemistry, the tumors showed aberrant nuclear staining for beta-catenin (8/8) and expression of CD56 (7/7), S100 (8/8), desmin (2/6), and androgen receptor (1/4). Pankeratin (AE1/AE3), progesterone receptor, synaptophysin, chromogranin, and INSM1 were negative. All tested cases harbored CTNNB1 mutations. Using a customized cohort, methylation profiling revealed that PS formed a common cluster with solid pseudopapillary neoplasm of the pancreas (SPNP), distinct from all methylation classes from the Heidelberg sarcoma classifier and a subset of paragangliomas. Transcriptomic analysis showed that PS formed an independent cluster from a control group of tumors (including SPNP). Differential gene expression analysis showed enrichment in genes of the Wnt signaling pathway (HALLMARK gene sets) and biological processes related to sensory perception, among others (gene ontology - biological process [GO-BP]). Additionally, upregulated genes were related to various fetal cell types from the cell type signature data set (MSigDB), particularly of neuronal and epithelial lineage. Immunohistochemical assessment of potential markers identified through gene expression analysis revealed focal-to-diffuse expression of GLUT1 (6/6) and focal/multifocal expression of Brachyury (4/9) and HuD (3/7). Follow-up information, available for 10 cases (median duration of 18 months; range, 7-69 months), showed local recurrences and metastatic spread in 2 patients each. Evidence of response to radiotherapy was documented in one tumor. Altogether, this study expands knowledge on PS and suggests biological links with SPNP, including a potential shared cell of origin.
假内分泌肉瘤(PS)是一种最近描述的分化不确定的肿瘤,其特征为CTNNB1基因反复突变、常位于椎旁以及具有神经内分泌样组织形态学。在本研究中,我们报告了12例PS病例的临床病理、免疫组化、转录组和表观遗传学结果。这些肿瘤累及7名男性和5名女性,中位年龄为66岁,位于脊柱旁/椎旁区域(n = 11)和大腿(n = 1)。肿瘤中位大小为82 mm(范围32 - 170 mm)。组织学上,肿瘤由上皮样至卵圆形细胞的片状和巢状结构组成,细胞核均匀,染色质呈斑点状,常伴有细胞外透明小球和纤维血管索/间隔。罕见表现包括微钙化、黏液样间质、假乳头、假腺管、微囊或条索状结构以及管腔和玫瑰花结样结构。无坏死,有丝分裂活性低。免疫组化显示,肿瘤β-连环蛋白核染色异常(8/8),CD56(7/7)、S100(8/8)、结蛋白(2/6)和雄激素受体(1/4)表达。全角蛋白(AE1/AE3)、孕激素受体、突触素、嗜铬粒蛋白和INSM1均为阴性。所有检测病例均存在CTNNB1突变。使用定制队列进行甲基化分析显示,PS与胰腺实性假乳头状肿瘤(SPNP)形成一个共同聚类,与海德堡肉瘤分类器的所有甲基化类别以及一部分副神经节瘤不同。转录组分析表明,PS与一组肿瘤对照组(包括SPNP)形成独立聚类。差异基因表达分析显示Wnt信号通路基因(HALLMARK基因集)以及与感觉感知等相关的生物学过程(基因本体 - 生物学过程[GO - BP])富集。此外,上调基因与细胞类型特征数据集(MSigDB)中的各种胎儿细胞类型相关,特别是神经元和上皮谱系。通过基因表达分析确定的潜在标志物的免疫组化评估显示,GLUT1呈局灶性至弥漫性表达(6/6),Brachyury呈局灶性/多灶性表达(4/9),HuD呈局灶性表达(3/7)。10例患者有随访信息(中位随访时间18个月;范围7 - 69个月),各有2例出现局部复发和转移扩散。有一个肿瘤记录了对放疗有反应的证据。总之,本研究扩展了对PS的认识,并提示其与SPNP存在生物学联系,包括潜在共同的起源细胞。